Millennium Management’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,604
Closed -$18.6K 6263
2024
Q4
$18.6K Buy
19,604
+7,541
+63% +$11.8K ﹤0.01% 5717
2024
Q3
$20K Sell
12,063
-14,430
-54% -$26.4K ﹤0.01% 5801
2024
Q2
$47.7K Buy
26,493
+6,465
+32% +$17.1K ﹤0.01% 5422
2024
Q1
$66.7K Sell
20,028
-8,035
-29% -$17.7K ﹤0.01% 5647
2023
Q4
$44.3K Sell
28,063
-35,946
-56% -$51.3K ﹤0.01% 5500
2023
Q3
$95.4K Sell
64,009
-16,365
-20% -$29.3K ﹤0.01% 5354
2023
Q2
$163K Buy
+80,374
New +$148K ﹤0.01% 5195
2022
Q4
Sell
-39,163
Closed -$179K 6890
2022
Q3
$179K Sell
39,163
-57,242
-59% -$158K ﹤0.01% 5715
2022
Q2
$276K Sell
96,405
-54,225
-36% -$188K ﹤0.01% 5436
2022
Q1
$663K Buy
150,630
+109,392
+265% +$556K ﹤0.01% 4895
2021
Q4
$227K Sell
41,238
-30,595
-43% -$201K ﹤0.01% 5799
2021
Q3
$425K Sell
71,833
-66,998
-48% -$482K ﹤0.01% 5496
2021
Q2
$1.51M Sell
138,831
-87,374
-39% -$1.08M ﹤0.01% 4258
2021
Q1
$3.44M Buy
+226,205
New +$3.11M ﹤0.01% 2993

Other funds holding LVTX